M. Husain Et Al. , "Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6," Cardiovascular Diabetology , vol.21, no.1, 2022
Husain, M. Et Al. 2022. Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6. Cardiovascular Diabetology , vol.21, no.1 .
Husain, M., Consoli, A., De Remigis, A., Pettersson Meyer, A. S., Rasmussen, S., & Bain, S., (2022). Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6. Cardiovascular Diabetology , vol.21, no.1.
Husain, Mansoor Et Al. "Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6," Cardiovascular Diabetology , vol.21, no.1, 2022
Husain, Mansoor Et Al. "Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6." Cardiovascular Diabetology , vol.21, no.1, 2022
Husain, M. Et Al. (2022) . "Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6." Cardiovascular Diabetology , vol.21, no.1.
@article{article, author={Mansoor Husain Et Al. }, title={Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6}, journal={Cardiovascular Diabetology}, year=2022}